| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.178.10.6581 |
| P698 | PubMed publication ID | 17475889 |
| P50 | author | Sharon R. Lewin | Q37618308 |
| Paul Urquhart Cameron | Q67957474 | ||
| Suzanne Crowe | Q96115329 | ||
| Ya-Lin Chiu | Q118383022 | ||
| Geza Paukovics | Q118383023 | ||
| P2093 | author name string | Warner C Greene | |
| Paul R Gorry | |||
| Secondo Sonza | |||
| Ajantha Solomon | |||
| Anthony Jaworowski | |||
| Emma Tippett | |||
| Philip J Ellery | |||
| P2860 | cites work | Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells | Q40435387 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 6581-6589 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo | |
| P478 | volume | 178 |
| Q39823471 | A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection |
| Q37080617 | APOBEC3 proteins and reverse transcription |
| Q28754989 | APOBEC3G: an intracellular centurion |
| Q37980423 | Achieving a cure for HIV infection: do we have reasons to be optimistic? |
| Q60047539 | Adipose Tissue T Cells in HIV/SIV Infection |
| Q40038736 | Adipose Tissue in HIV Infection |
| Q37122230 | Alterations in brain metabolism during the first year of HIV infection |
| Q39525582 | Analysis of multiple cell reservoirs expressing unspliced HIV-1 gag-pol mRNA in patients on antiretroviral therapy |
| Q34298792 | Antiretroviral therapy in macrophages: implication for HIV eradication |
| Q37128257 | Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination |
| Q52691274 | B cell, CD8 + T cell and gamma delta T cell lymphocytic alveolitis alters alveolar immune cell homeostasis in HIV-infected Malawian adults. |
| Q27693321 | Bioinformatic analysis of HIV-1 entry and pathogenesis |
| Q37862747 | Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection |
| Q35114694 | Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. |
| Q34376412 | CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders |
| Q89451196 | CCR2 on Peripheral Blood CD14+CD16+ Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs? |
| Q41925946 | CD14+CD16+ monocytes are the main target of Zika virus infection in peripheral blood mononuclear cells in a paediatric study in Nicaragua |
| Q40282329 | CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression |
| Q28910367 | CD4 ligation on human blood monocytes triggers macrophage differentiation and enhances HIV infection |
| Q37600700 | CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. |
| Q40201318 | CX3CR1+ monocytes modulate learning and learning-dependent dendritic spine remodeling via TNF-α. |
| Q36670527 | Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders |
| Q33892114 | Characterization of HIV-1 RNA forms in the plasma of patients undergoing successful HAART. |
| Q35105210 | Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS. |
| Q33573879 | Characterization of platelet-monocyte complexes in HIV-1-infected individuals: possible role in HIV-associated neuroinflammation |
| Q43438744 | Characterization of tetraspanins CD9, CD53, CD63, and CD81 in monocytes and macrophages in HIV-1 infection |
| Q26825762 | Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence |
| Q38748887 | Circulating monocytes are not a major reservoir of HIV-1 in elite suppressors |
| Q46531545 | Clinical Relevance of Total HIV DNA in Peripheral Blood Mononuclear Cell Compartments as a Biomarker of HIV-Associated Neurocognitive Disorders (HAND). |
| Q38214994 | Cognitive consequences of a sustained monocyte type 1 IFN response in HIV-1 infection |
| Q35909507 | Cognitive performance related to HIV-1-infected monocytes |
| Q56965879 | Comprehensive innate immune profiling of chikungunya virus infection in pediatric cases |
| Q99237987 | Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection |
| Q38115992 | Cytometry, immunology, and HIV infection: three decades of strong interactions. |
| Q41890127 | Cytoplasmic APOBEC3G restricts incoming Vif-positive human immunodeficiency virus type 1 and increases two-long terminal repeat circle formation in activated T-helper-subtype cells |
| Q36298503 | Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality. |
| Q37386023 | Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR. |
| Q37352656 | Different levels of HIV DNA copy numbers in cerebrospinal fluid cellular subsets |
| Q37047159 | Differential HIV epitope processing in monocytes and CD4 T cells affects cytotoxic T lymphocyte recognition |
| Q37122279 | Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy |
| Q27311668 | Distinct phenotype, longitudinal changes of numbers and cell-associated virus in blood dendritic cells in SIV-infected CD8-lymphocyte depleted macaques |
| Q37367171 | Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia |
| Q39275937 | Diverging biological roles among human monocyte subsets in the context of tuberculosis infection |
| Q37270321 | Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cells. |
| Q84079241 | Donor variation in in vitro HIV-1 susceptibility of monocyte-derived macrophages |
| Q40354055 | Dopamine Increases CD14+CD16+ Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis |
| Q27316037 | Dopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesis |
| Q35000860 | Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND. |
| Q38916260 | Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models. |
| Q35534768 | Effects of HIV-1 infection in vitro on transendothelial migration by monocytes and monocyte-derived macrophages. |
| Q34784783 | Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring? |
| Q35994939 | Elevation of Non-Classical (CD14+/lowCD16++) Monocytes Is Associated with Increased Albuminuria and Urine TGF-β1 in HIV-Infected Individuals on Stable Antiretroviral Therapy. |
| Q38096822 | Eliminating the latent HIV reservoir by reactivation strategies: advancing to clinical trials |
| Q35544355 | Eradication of HIV-1 from the macrophage reservoir: an uncertain goal? |
| Q30399588 | Eradication therapies for HIV Infection: time to begin again |
| Q33314468 | Expression of monocyte markers in HIV-1 infected individuals with or without HIV associated dementia and normal controls in Bangkok Thailand |
| Q42130105 | Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy |
| Q93177515 | Flow-cytometric analysis of human monocyte subsets targeted by Mycobacterium bovis BCG before granuloma formation |
| Q54201368 | Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14+ CD16+ monocytes. |
| Q38654347 | Frontline Science: CXCR7 mediates CD14(+)CD16(+) monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS. |
| Q36466553 | Further Evidence that Human Endogenous Retrovirus K102 is a Replication Competent Foamy Virus that may Antagonize HIV-1 Replication |
| Q26865707 | Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder |
| Q34870353 | Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir |
| Q90209104 | HCV cure in HIV coinfection dampens inflammation and improves cognition through multiple mechanisms |
| Q33805298 | HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications |
| Q35867173 | HIV RNA suppression and immune restoration: can we do better? |
| Q35607587 | HIV eradication symposium: will the brain be left behind? |
| Q38945041 | HIV infection: focus on the innate immune cells. |
| Q37229398 | HIV interactions with monocytes and dendritic cells: viral latency and reservoirs |
| Q36746403 | HIV reservoirs and latency models. |
| Q55967625 | HIV-1 and the macrophage |
| Q37726306 | HIV-1 assembly in macrophages |
| Q26825087 | HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies |
| Q28474374 | HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination |
| Q33733529 | HIV-1 neuroimmunity in the era of antiretroviral therapy. |
| Q36526530 | HIV-1 pathogenesis: the virus |
| Q37607912 | HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes |
| Q33513977 | HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy. |
| Q37720509 | HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment. |
| Q47342684 | HIV-infected cannabis users have lower circulating CD16+ monocytes and IP-10 levels compared to non-using HIV patients |
| Q35857927 | Highly Active Antiretroviral Therapy (HAART)-Related Hypertriglyceridemia Is Associated With Failure of Recovery of CD14lowCD16+ Monocyte Subsets in AIDS Patients |
| Q33846376 | Host hindrance to HIV-1 replication in monocytes and macrophages |
| Q90206556 | Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases |
| Q47141069 | Human Primary Macrophages Derived In Vitro from Circulating Monocytes Comprise Adherent and Non-Adherent Subsets with Differential Expression of Siglec-1 and CD4 and Permissiveness to HIV-1 Infection |
| Q37671958 | Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species |
| Q38645990 | Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications |
| Q40530005 | Immature monocytes contribute to cardiopulmonary bypass-induced acute lung injury by generating inflammatory descendants |
| Q39048479 | Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy |
| Q36556082 | Immune activation and cardiovascular disease in chronic HIV infection |
| Q30593046 | Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort |
| Q92136409 | Impact of Myeloid Reservoirs in HIV Cure Trials |
| Q89458435 | In vitro Infection of Primary Human Monocytes with HIV-1 |
| Q41260322 | Increased expression of monocyte CD44v6 correlates with the deveopment of encephalitis in rhesus macaques infected with simian immunodeficiency virus |
| Q90616753 | Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy |
| Q36281845 | Inhibition of HIV Expression and Integration in Macrophages by Methylglyoxal-Bis-Guanylhydrazone |
| Q33815410 | Interactions between HIV-1 and mucosal cells in the female reproductive tract |
| Q98158482 | Interactions of Monocytes, HIV, and ART Identified by an Innovative scRNAseq Pipeline: Pathways to Reservoirs and HIV-Associated Comorbidities |
| Q26861003 | Interferon-alpha, immune activation and immune dysfunction in treated HIV infection |
| Q35005863 | JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals |
| Q98735449 | Macrophage Polarization in Leprosy-HIV Co-infected Patients |
| Q35823900 | Macrophage colony stimulating factor regulation by nuclear factor kappa B: a relevant pathway in human immunodeficiency virus type 1 infected macrophages |
| Q37665065 | Macrophage polarization and HIV-1 infection. |
| Q37182704 | Macrophages in Progressive Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections |
| Q36737917 | Macrophages sustain HIV replication in vivo independently of T cells |
| Q35091012 | Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule |
| Q42638904 | Mechanisms of CNS Viral Seeding by HIV+ CD14+ CD16+ Monocytes: Establishment and Reseeding of Viral Reservoirs Contributing to HIV-Associated Neurocognitive Disorders |
| Q34902401 | Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis |
| Q33346244 | Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients |
| Q33873798 | Minocycline inhibition of monocyte activation correlates with neuronal protection in SIV neuroAIDS |
| Q35812057 | Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease |
| Q39622803 | Molecular Understanding of HIV-1 Latency |
| Q33864438 | Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage |
| Q37726311 | Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection |
| Q40145888 | Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage |
| Q35787684 | Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis |
| Q49977521 | Monocyte subsets exhibit transcriptional plasticity and a shared response to interferon in SIV-infected rhesus macaques. |
| Q28751900 | Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies |
| Q36991666 | Monocyte/macrophages and their role in HIV neuropathogenesis |
| Q27006827 | Monocytes as regulators of inflammation and HIV-related comorbidities during cART |
| Q35108968 | Monocytes expand with immune dysregulation and is associated with insulin resistance in older individuals with chronic HIV. |
| Q35154529 | Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders |
| Q35665916 | Mucosal and peripheral Lin- HLA-DR+ CD11c/123- CD13+ CD14- mononuclear cells are preferentially infected during acute simian immunodeficiency virus infection |
| Q47141408 | Myeloid Cell Interaction with HIV: A Complex Relationship. |
| Q35067224 | Myeloid dendritic cells induce HIV-1 latency in non-proliferating CD4+ T cells |
| Q54517758 | No reliable gene expression biomarkers of current or impending neurocognitive impairment in peripheral blood monocytes of persons living with HIV. |
| Q36966437 | Non-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapy |
| Q33842214 | Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis |
| Q59361053 | Peering into the HIV reservoir |
| Q40315607 | Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria |
| Q34941973 | Pharmaceutical approaches to eradication of persistent HIV infection |
| Q94475288 | Phyloanatomic characterization of the distinct T cell and monocyte contributions to the peripheral blood HIV population within the host |
| Q34788837 | Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy. |
| Q97524620 | Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders |
| Q35956508 | Proline-proline-glutamic acid (PPE) protein Rv1168c of Mycobacterium tuberculosis augments transcription from HIV-1 long terminal repeat promoter. |
| Q33770687 | Proteomic analysis of HIV-infected macrophages |
| Q34127415 | R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes |
| Q34607733 | RNA sequencing and transcriptomal analysis of human monocyte to macrophage differentiation |
| Q33822185 | Rational design of immunostimulatory siRNAs. |
| Q47558110 | Regulation of CD4 Receptor and HIV-1 Entry by MicroRNAs-221 and -222 during Differentiation of THP-1 Cells. |
| Q28391037 | Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj |
| Q45252370 | Revising the Role of Myeloid cells in HIV Pathogenesis. |
| Q47100536 | Role of Monocyte/Macrophages during HIV/SIV Infection in Adult and Pediatric Acquired Immune Deficiency Syndrome |
| Q90364610 | SLAMF7 Is a Critical Negative Regulator of IFN-α-Mediated CXCL10 Production in Chronic HIV Infection |
| Q84952244 | Selective expansion of pro-inflammatory chemokine CCL2-loaded CD14+CD16+ monocytes subset in HIV-infected therapy naïve individuals |
| Q34992712 | Shift in monocyte apoptosis with increasing viral load and change in apoptosis-related ISG/Bcl2 family gene expression in chronically HIV-1-infected subjects |
| Q40349561 | Short communication: Human blood dendritic cells are infected separately from monocytes in HIV type 1 patients |
| Q36498220 | Single-cell, phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection |
| Q33562292 | Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function |
| Q40738275 | Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders. |
| Q47160410 | Sugar or Fat?-Metabolic Requirements for Immunity to Viral Infections |
| Q35993749 | Sulforaphane Inhibits HIV Infection of Macrophages through Nrf2. |
| Q34264672 | Susceptibility and response of human blood monocyte subsets to primary dengue virus infection |
| Q33300132 | T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity |
| Q50131761 | The Biology of Monocytes and Dendritic Cells: Contribution to HIV Pathogenesis |
| Q34545398 | The CD14(+/low)CD16(+) monocyte subset is more susceptible to spontaneous and oxidant-induced apoptosis than the CD14(+)CD16(-) subset |
| Q38239283 | The FcγR of humans and non-human primates and their interaction with IgG: implications for induction of inflammation, resistance to infection and the use of therapeutic monoclonal antibodies |
| Q91811483 | The HIV Reservoir in Monocytes and Macrophages |
| Q36856091 | The HIV-1 env protein: a coat of many colors |
| Q41954397 | The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time |
| Q42160092 | The Impact of Macrophage Nucleotide Pools on HIV-1 Reverse Transcription, Viral Replication, and the Development of Novel Antiviral Agents |
| Q38777355 | The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells |
| Q91790814 | The Mtb-HIV syndemic interaction: why treating M. tuberculosis infection may be crucial for HIV-1 eradication |
| Q39224160 | The Role of HIV Infection in Neurologic Injury. |
| Q92188718 | The Role of Macrophages in HIV-1 Persistence and Pathogenesis |
| Q40120177 | The immunosuppressive domain of the transmembrane envelope protein gp41 of HIV-1 binds to human monocytes and B cells |
| Q43505499 | The importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure. |
| Q34898069 | The macrophage: the intersection between HIV infection and atherosclerosis. |
| Q54237426 | The pathway to establishing HIV latency is critical to how latency is maintained and reversed. |
| Q33608155 | The role of HIV and monocytes/macrophages in adipose tissue biology |
| Q53828206 | The role of catecholamines in HIV neuropathogenesis. |
| Q41812539 | The role of cytidine deaminases on innate immune responses against human viral infections. |
| Q37995036 | The three human monocyte subsets: implications for health and disease |
| Q37191794 | Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain |
| Q37504330 | Transcriptional profiling reveals molecular signatures associated with HIV permissiveness in Th1Th17 cells and identifies peroxisome proliferator-activated receptor gamma as an intrinsic negative regulator of viral replication |
| Q37145340 | Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes |
| Q37374036 | Transcriptome analysis of HIV-infected peripheral blood monocytes: gene transcripts and networks associated with neurocognitive functioning |
| Q92653354 | Tuberculosis Exacerbates HIV-1 Infection through IL-10/STAT3-Dependent Tunneling Nanotube Formation in Macrophages |
| Q35264787 | Understanding the MIND phenotype: macrophage/microglia inflammation in neurocognitive disorders related to human immunodeficiency virus infection |
| Q60949705 | Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved? |
| Q37119030 | Vif and Apobec3G in the innate immune response to HIV: a tale of two proteins |
| Q38217388 | Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND) |
| Q33763354 | miRNA-1236 inhibits HIV-1 infection of monocytes by repressing translation of cellular factor VprBP. |
| Q33605261 | Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection |
| Q42216587 | β-Catenin/TCF-4 signaling regulates susceptibility of macrophages and resistance of monocytes to HIV-1 productive infection |
Search more.